🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07096206
Active, not recruiting Observational

Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International Study

NCT07096206 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2023-07-19
Last updated
2025-07-31

Condition(s) studied

X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

Study summary

This is an observational, multicentre, international study over a 2-year follow-up period.

The aim of this study is to understand how XLHED affects the lives of young male patients and their families over time. By studying the natural course of the disease and its impact, the study could improve the understanding of the challenges faced by these patients and their families.

Eligibility

Sex
MALE
Min age
0 Years
Max age
11 Years
Healthy volunteers
No
Inclusion Criteria: * Boy * Age at inclusion: from birth to the day before the 11th birthday * XLHED disease that has been diagnosed by: * genetic testing or * symptoms (sweating ability, teeth and hair impairment) and genetic diagnosis of the mother Exclusion Criteria: * Any previous treatment with ER004 or participation in a clinical trial testing ER004 * Testing for XLHED disease with a negative result

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Necker hospital Paris France
Uniklinikum Erlangen Erlangen Germany

More Pierre Fabre Medicament trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07096206 on ClinicalTrials.gov ↗ ← All trials in Germany